Onkologische Gemeinschaftspraxis

What Onkologische Gemeinschaftspraxis does

Onkologische Gemeinschaftspraxis is a privately held outpatient hematology and oncology specialist medical practice (Gemeinschaftspraxis) headquartered in Munich-Pasing, Bavaria, Germany. Founded in 1986 by Dr. med. A. Wohlrab as one of Munich's oldest hematology-oncology specialist practices, it transitioned to a partnership structure on July 1, 2014, with the addition of Dr. med. Juliane Wagner-Czekalla, who assumed full ownership upon Dr. Wohlrab's retirement on December 31, 2023. Dr. med. Norbert Fischer joined as a colleague physician effective January 1, 2024. The practice operates with 8 employees across a single site and serves statutory (GKV) and private (PKV) health insurance patients as well as self-pay patients on an appointment-only basis.

The practice offers an integrated continuum of diagnostic, therapeutic, and supportive care services. Diagnostic capabilities include medical history, physical examination, sonography, ECG, bone marrow punctures, pleural/ascites/lumbar punctures, an in-house rapid hematology laboratory, specialized cytological analysis, tumor marker determination, immune system analysis, and coagulation analysis. Therapeutic services encompass intravenous and oral chemotherapy, chemotherapy pump systems, antibody and immunotherapy, blood transfusions, pain therapy, palliative care, and acupuncture. The practice is augmented by an extensive interdisciplinary network spanning more than 15 medical specialties and partnerships with leading Munich institutions (Isar Klinikum, Klinikum Großhadern, HELIOS Klinikum München West, Städt. Klinikum München, KH Martha Maria) plus the MLL Münchner Leukämie Labor for cytogenetic, molecular genetic, and mutation diagnostics. Doctolib is integrated for online appointment booking.

Revenue is generated entirely through regulated German healthcare reimbursement: standard GKV statutory insurance billing under the EBM catalog, PKV private insurance billing under GOÄ, and self-pay for non-covered services. The practice has held DIN EN ISO 9001 quality management certification continuously since 2005, and operates under Kassenärztliche Vereinigung Bayerns (KVB) regulation and Bayerische Landesärztekammer oversight. Distribution is sales-led via professional medical referrals and active participation in interdisciplinary tumor boards, supplemented by Doctolib's self-serve booking channel.

Name

Onkologische Gemeinschaftspraxis

Legal name

Onkologische Facharztpraxis

Website

https://onkologische-gemeinschaftspraxis-muenchen.de

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1–10 employees

Short description

Onkologische Gemeinschaftspraxis is a Munich-based outpatient hematology and oncology specialist practice offering diagnostics, chemotherapy, immunotherapy, and palliative care, serving GKV/PKV-insured patients through physician referrals and an interdisciplinary partnership network since 1986.

Ownership category

akta.pro rank

Headquarters

HQ city

Munich-Pasing

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Statutory Health Insurance (GKV): Standard German statutory health insurance reimbursement for covered medical services in hematology and oncology treatment.
2. Private Health Insurance (PKV): Private health insurance reimbursement for services provided to privately insured patients.
3. Self-Paying Patients: Direct payment from patients for services not covered by insurance plans.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Onkologische Gemeinschaftspraxis is an outpatient hematology and oncology specialist practice providing the complete spectrum of services needed for diagnosis, therapy, and specialist care of hematological and oncological diseases. Core offerings include diagnostic services (specialized anamnesis, sonography, EKG, bone marrow puncture, cytological analysis, tumor marker determination, immune system analysis), therapy services (intravenous and oral chemotherapy, antibody and immunotherapy, blood transfusions, pain therapy, palliative care, acupuncture), and ongoing patient support services (home care coordination, parenteral nutrition at home, 24-hour emergency availability, palliative care).

Product overview

Onkologische Gemeinschaftspraxis is a hematology and oncology specialist medical practice offering a unified portfolio of diagnostic, therapeutic, and patient care services. The practice functions as a single integrated offering where diagnostics (laboratory analysis, imaging, tumor markers), therapy (chemotherapy, immunotherapy, transfusions, pain management), and ongoing patient support (home care coordination, palliative care, 24-hour emergency availability) work together as a coordinated care continuum. Established in 1986 and operated as a joint practice since 2014, the practice serves oncology and hematology patients through comprehensive in-house capabilities supplemented by an extensive network of medical partnerships for imaging, pathology, and specialized treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostics (Diagnostik) Comprehensive diagnostic services for hematological and oncological diseases, including specialized anamnesis, sonography, EKG, bone marrow punctures, cytological analysis, tumor marker determination, and immune system analysis, performed in-house with a hematological rapid laboratory for adult patients with suspected or confirmed blood or cancer diseases.
• Therapy (Therapie) Outpatient cancer treatment services including intravenous and oral chemotherapy, chemotherapy pump systems, antibody and immunotherapy, blood transfusions, pain management, palliative care, and acupuncture for adult hematology and oncology patients, delivered primarily on an ambulatory basis that allows patients to return home after infusion sessions.
• Patient Care and Support (Betreuung) Comprehensive patient support services including coordination of home care, parenteral nutrition at home, home visits, palliative care for seriously ill patients, and 24-hour emergency telephone availability for existing hematology and oncology patients.

Quantifiable outcome

• Ambulatory treatment approach significantly improves quality of life and flexibility for patients in difficult illness situations by allowing them to return home after infusion therapy.
• +1 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• Isar Klinikum MünchencoreStrategic or Co-development PartnerInterdisciplinary Tumor Board collaboration with Director PD. Dr. H. Seidl. General surgery partnership with Prof. Heitland/PD. Dr. Bader for multimodal treatment coordination.
• KH Martha MariacoreStrategic or Co-development PartnerInterdisciplinary Tumor Board collaboration led by Prof. Dr. H. Fürst for comprehensive cancer care planning.
• MLL (Münchner Leukämie Labor)coreTechnology or IntegrationPartnership with Prof. Dr. med. Haferlach's specialized leukemia laboratory for cytogenetic, molecular genetic, and mutation diagnostics.
• HELIOS Klinikum München WestcoreStrategic or Co-development PartnerRadiation therapy partnership with Dres Gilleßen/Stoll/Schweden for comprehensive oncological treatment options.
• Klinikum GroßhaderncoreStrategic or Co-development PartnerOncology partnership with Prof. Dr. med. Heinemann and thoracic surgery with Prof. Dr. med. R. Hatz for advanced cancer treatment.
• Städt. Klinikum München GmbHcoreStrategic or Co-development PartnerOncology partnership with Prof. Dr. Wendtner/LOA Dr. Fischer at Kölner Platz 1 location.

Scale indicators2 records

Recent moves8 records

Expansion highlights4 records

Others

• Doctolib: European digital health platform providing online appointment booking and patient communication tools; integrated into the subject practice's website for online scheduling. Adjacent enabling technology rather than a direct clinical competitor.

Broad incumbents

• HELIOS Klinikum München West: Private hospital network with oncology and radiation therapy services at its Munich West location, currently a radiation therapy partner of the subject practice. Comparable as a Munich-located oncology provider at greater scale.
• Städtisches Klinikum München (Klinikum Schwabing) - Hämatologie/Onkologie: Municipal Munich hospital system with hematology/oncology outpatient services, led by Prof. Wendtner, where the subject practice's lead physician previously served as Oberärztin for 9 years. Competes in the same Munich catchment via hospital-based outpatient oncology.
• Klinikum der Universität München (LMU Klinikum) - Hämatologie/Onkologie: Major Munich academic medical center with comprehensive hematology and oncology inpatient and outpatient services. Comparable as a Munich-area hematology/oncology provider competing for the same patient pool, but operates at significantly larger scale with clinical trial access and tertiary referral positioning.
• Klinikum rechts der Isar der TU München (TUM Klinikum) - Onkologie: Second large Munich university hospital with active oncology and hematology service lines that the subject practice collaborates with via tumor boards at Isar Klinikum. Overlapping regional catchment and broader scope make it a broad-incumbent comparison.

Regional players

• Sana Kliniken - Onkologische Versorgung: German private hospital group with oncology service lines and outpatient clinics across Germany. Comparable German oncology operator of significantly larger scale, providing a structural benchmark for practice group consolidations and MVZ-style growth.
• Asklepios Kliniken - Onkologische Zentren: Large German private hospital operator running oncology centers and MVZs across multiple federal states. Comparable to the subject practice as a multi-site outpatient and inpatient hematology/oncology provider, though operating at materially larger scale and across broader geography.

Direct peers

• MLL Münchner Leukämie Labor: Munich-based specialized leukemia and hematology diagnostics laboratory partnered with the subject practice for cytogenetic, molecular genetic, and mutation testing. Highly comparable as a Munich-located hematology/oncology-focused diagnostic specialist serving overlapping patient populations and referral networks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/onkologische-gemeinschaftspraxis

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onkologische Gemeinschaftspraxis